The global immunoglobulin market size reached US$ 15.7 Billion in 2023. Looking forward, the publisher expects the market to reach US$ 24.9 Billion by 2032, exhibiting a growth rate (CAGR) of 5.26% during 2023-2032.
Also known as antibodies, immunoglobulins refer to a class of glycoprotein molecules produced by plasma or white blood cells (WBCs). They are generally present in the serum and cells of the immune system and function as antibodies by explicitly recognizing and binding antigens, such as bacteria or viruses, and aiding in their destruction. Their tests help doctors diagnose immunodeficiencies, allergies, and autoimmune conditions like juvenile idiopathic arthritis, lupus, and celiac disease. At present, different classes of immunoglobulins are available around the world depending on biological features, structure, target specificity, and distribution.
As a result, with the rising number of hospitalized patients with coronavirus disease (COVID-19) and an urgent need for effective therapies to prevent the spread of the pandemic, hyperimmune globulin is utilized as an effective medicine in managing the infection. Apart from this, several pharmaceutical companies are introducing new and advanced immunoglobulins with improved efficiency for the treatment of neurological disorders. Other factors, such as increasing funding for research and development (R&D) projects and the improving healthcare infrastructure are anticipated to propel the market growth further in the coming years.
2. What is the expected growth rate of the global immunoglobulin market during 2024-2032?
3. What are the key factors driving the global immunoglobulin market?
4. What has been the impact of COVID-19 on the global immunoglobulin market?
5. What is the breakup of the global immunoglobulin market based on the application?
6. What is the breakup of the global immunoglobulin market based on the mode of delivery?
7. What are the key regions in the global immunoglobulin market?
8. Who are the key players/companies in the global immunoglobulin market?
Also known as antibodies, immunoglobulins refer to a class of glycoprotein molecules produced by plasma or white blood cells (WBCs). They are generally present in the serum and cells of the immune system and function as antibodies by explicitly recognizing and binding antigens, such as bacteria or viruses, and aiding in their destruction. Their tests help doctors diagnose immunodeficiencies, allergies, and autoimmune conditions like juvenile idiopathic arthritis, lupus, and celiac disease. At present, different classes of immunoglobulins are available around the world depending on biological features, structure, target specificity, and distribution.
Immunoglobulin Market Trends:
Due to rapid urbanization and hectic schedules, there is a rise in the consumption of fast food among individuals. This, along with sedentary lifestyles and the increasing number of patients with medical conditions like multiple myeloma, Waldenstrom macroglobulinemia, and autoimmune disorders, represents one of the primary factors impelling the growth of the market. Additionally, rising awareness about early diagnosis and the increasing preferences for personalized medicines are contributing to market growth. Moreover, immunoglobulins through a variety of routes of administration help the body fight various infectious diseases.As a result, with the rising number of hospitalized patients with coronavirus disease (COVID-19) and an urgent need for effective therapies to prevent the spread of the pandemic, hyperimmune globulin is utilized as an effective medicine in managing the infection. Apart from this, several pharmaceutical companies are introducing new and advanced immunoglobulins with improved efficiency for the treatment of neurological disorders. Other factors, such as increasing funding for research and development (R&D) projects and the improving healthcare infrastructure are anticipated to propel the market growth further in the coming years.
Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global immunoglobulin market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on product, application and mode of delivery.Breakup by Product:
- IgG
- IgA
- IgM
- IgE
- IgD
Breakup by Application:
- Hypogammaglobulinemia
- Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
- Immunodeficiency Disease
- Myasthenia Gravis
- Others
Breakup by Mode of Delivery:
- Intravenous Mode of Delivery
- Subcutaneous Mode of Delivery
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being ADMA Biologics Inc., Baxter international Inc., Biotest AG, CSL Limited, Grifols S.A, Kedrion S.p.A, LFB SA, Octapharma AG, Sanquin Plasma Products B.V. and Takeda Pharmaceutical Company Limited.Key Questions Answered in This Report
1. What was the size of the global immunoglobulin market in 2023?2. What is the expected growth rate of the global immunoglobulin market during 2024-2032?
3. What are the key factors driving the global immunoglobulin market?
4. What has been the impact of COVID-19 on the global immunoglobulin market?
5. What is the breakup of the global immunoglobulin market based on the application?
6. What is the breakup of the global immunoglobulin market based on the mode of delivery?
7. What are the key regions in the global immunoglobulin market?
8. Who are the key players/companies in the global immunoglobulin market?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Immunoglobulin Market
6 Market Breakup by Product
7 Market Breakup by Application
8 Market Breakup by Mode of Delivery
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
List of Figures
List of Tables
Companies Mentioned
- ADMA Biologics Inc.
- Baxter international Inc.
- Biotest AG
- CSL Limited
- Grifols S.A
- Kedrion S.p.A
- LFB SA
- Octapharma AG
- Sanquin Plasma Products B.V.
- Takeda Pharmaceutical Company Limited
Methodology
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 140 |
| Published | August 2024 |
| Forecast Period | 2023 - 2032 |
| Estimated Market Value ( USD | $ 15.7 Billion |
| Forecasted Market Value ( USD | $ 24.9 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
